Aktieanalys

Cyxone: Additional Information from the Rabeximod Covid-19 Trial - Redeye

{newsItem.title}

Redeye Publicerad: 04 Apr 2022 07:32

We give a short comment on the additional information from the phase II trial with Rabeximod in Covid-19 patients.

Länk till analysen i sin helhet: https://www.redeye.se/research/837614/cyxone-additional-information-from-the-rabeximod-covid-19-trial?utm_source=finwire&utm_medium=RSS

Nyheter om Cyxone

Läses av andra just nu

Om aktien Cyxone

Senaste nytt